CN Patent

CN109575021B — 一种哌柏西利的制备方法

Assigned to Beijing Haimeitong Medical Technology Co ltd · Expires 2020-09-18 · 6y expired

What this patent protects

一种哌柏西利的制备方法，涉及有机合成领域，其以化合物I作为起始原料，通过五步反应即可得到哌柏西利。其操作简单，对设备要求不高，原料易得，反应条件较为温和，并且具有较高的产率，适合应用于工业化生产。

USPTO Abstract

一种哌柏西利的制备方法，涉及有机合成领域，其以化合物I作为起始原料，通过五步反应即可得到哌柏西利。其操作简单，对设备要求不高，原料易得，反应条件较为温和，并且具有较高的产率，适合应用于工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN109575021B
Jurisdiction
CN
Classification
—
Expires
2020-09-18
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Haimeitong Medical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.